Georgia's Largest Public Health Agency Signs Deal With Clinlab for New Lab Information System

Contract Is Largest for Clinlab Since It Was Acquired by Rennova Health


WEST PALM BEACH, FL--(Marketwired - Jan 26, 2016) - Clinlab, Inc., a subsidiary of Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) that develops and markets laboratory information and automation systems, announced today it has entered into an agreement with the Fulton County Department of Health & Wellness to provide technology for faster, more efficient processing and reporting of lab tests.

The Atlanta health department is the largest in Georgia, serving nearly one million people and employing more than 700 healthcare professionals, support staff, and outreach personnel. This is Clinlab's largest deal since it joined the Rennova family of companies, and it is the second-largest transaction in Clinlab's history.

Laboratory information systems, like Clinlab's, are used in hospital-based labs, office-based labs at physician practices, large clinics, as well as in major reference laboratories that handle tens of thousands of tests. For Fulton County, Clinlab will install its system in a variety of work environments, including lab workstations, offices, and mobile devices used in the field. Moreover, the Clinlab system will increase automation and reduce the reliance on manual processing of tests. It will also reduce the Health Department's dependence on outsourced lab services. Consequently, the system has the potential to dramatically reduce the County's spending on laboratory services and expedite test results.

"Fulton County will benefit from faster turnaround of lab tests and significant cost savings," said Allen Wilson, chief operating officer of Clinlab. "In addition, our system will have a positive impact on public health by allowing the providers at the County's clinics to access patient health records that include a more thorough history of laboratory results -- compiled from state electronic health records and third-party labs."

Clinlab has extensive experience working with other public entities, including the University of Florida, the University of New Mexico, Texas A&M University, Florida State Hospital, and Northeast Florida State Hospital. The company recently launched new technology specifically designed for laboratories that handle toxicology testing, such as those labs owned by Clinlab's parent company, Rennova Health. Rennova operates labs across the U.S. that serve the toxicology testing needs of drug and alcohol rehabilitation facilities and pain management clinics.

"Fulton County's selection of Clinlab serves as testament to our product's capacity to meet the unique needs of a major public health department while reducing operating costs and positively affecting the health of the population it serves," said Seamus Lagan, CEO of Rennova Health, Inc. "It's an exciting step for Clinlab and just the beginning of a healthier future for Fulton County."

For more information about Clinlab or Rennova Health, Inc., visit www.rennovahealth.com. Media inquiries may be directed to Meieli Sawyer at msawyer@weinbachgroup.com.

About Rennova Health
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) owns and operates five diagnostics laboratories across the United States that provide clinical testing services specializing in toxicology testing for pain management clinics, drug and alcohol rehabilitation facilities and neurotransmitter testing. It offers its customers a complete, turnkey software product including: a proprietary laboratory ordering and reporting application, an advanced laboratory information management system, electronic health records, and an industry-leading platform for interpreting and reporting complex test results to physicians. Rennova's software is differentiated from that of its competitors by the breadth of its services, each of which is branded separately and is made available to physician groups in whole or in part. The software permits efficient and easy ordering and reporting, electronic health records integration, medical billing services and compliance, and diagnostic interpretation. For more information see www.rennovahealth.com.

About Clinlab, Inc.
Clinlab, Inc. is a turnkey Windows-based, Internet- and web-enabled Laboratory Information management System (LIS) for the modern small to medium sized clinical lab. Designed by medical technologists, Clinlab can be customized to meet the needs of any laboratory acting as a data warehouse for all lab results and includes reporting, data acquisition, label printing, electronic signoff, and more. Clinlab's highly secure remote access features allow it to connect to multi-location databases to view patient orders and results from any location; support electronic communication between labs, physicians, and other departments; and provide managers with a complete set of quality and control tools to meet the custom security needs of their facility, as well as HIPAA and other regulatory requirements. Seamlessly interfacing with other information systems, including HIS/Practice Management/EMR, Clinlab also supports bi-directional interfaces to national and regional reference labs and is dedicated to improving laboratory productivity and compliance.

Rennova Health Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to significant risks and uncertainties, and actual results could differ materially from those projected and Rennova Health cautions investors not to place undue reliance on the forward-looking statements contained in this release. Important factors that could cause Rennova Health's actual results or performance to differ materially from the forward-looking statements include those set forth in Rennova's filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Rennova Health undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

Contact Information:

Contacts
Rennova Health Media Contact:
Sebastien Sainsbury

(561) 666-9818

Investors:
LHA
Kim Golodetz

(212) 838-3777

Or

Bruce Voss

(310) 691-7100